PharmaBoardroom

Svens Henkuzens, director of the State Agency of Medicines in Latvia discusses the key role of the organization in the country and the objectives he…

Evija Buksa, general manager at Merck in Latvia, explains the strong history of Merck in the country as well as its key role in participating in the…

Juan Carlos Galarza, executive director of Ecuador’s National Health Regulation, Control and Surveillance Agency (ARCSA), discusses the multiple…

Much of the new inward investment in the UK from international pharmaceutical companies is from those that wish their discovery science to be in…

Simon Gillespie of the British Heart Foundation (BHF), the UK’s leading national heart charity, outlines the organization’s mission, the issues…

“Brazil undoubtedly holds great development opportunities for the global pharmaceutical and healthcare industries,” boldly states Minister of…

SIFFA’s Valters Bolēvics discusses Latvia’s competitiveness in embracing medical innovations, current healthcare reforms, and the country’s…

Whitney Green candidly describes what first surprised him as an American coming to Canada to head up operations as president and general manager of…

Angel Guevara, molecular biologist and professor at the Central University of Ecuador (UCE), discusses Ecuador’s potential as a clinical trial…

Daina Klepone, managing director at Enterprise Lithuania, explains the opportunities Lithuania can offer to healthcare businesses and how their…

Serbia macroeconomic factsheet including data on population, GDP, education and life expectancy. Serbia has risen 50 places in the World…

Vytautas Baublys, co-founder and CEO of Softneta, introduces the award-winning Lithuanian IT company, and its service offering, explaining how…